HIVMA and the IDSA Foundation are pleased to announce the selection of 15 medical students from across the US who will receive funding for clinical learning and research projects through the HIVMA Medical Students Program.
HIVMA and the IDSA Foundation are pleased to announce the selection of 15 medical students from across the US who will receive funding for clinical learning and research projects through the HIVMA Medical Students Program.
The House Appropriations Labor-HHS subcommittee today passed a funding bill that undercuts several critical components of the domestic HIV response with elimination of vital prevention and women’s health services, and stagnant funding for care programs.
The members of the HIV Medicine Association are deeply concerned by the U.S. Department of Justice’s decision not to defend the constitutionality of existing law protecting individuals with pre-existing conditions and providing other critical consumer protections to individuals in healthcare insurance markets as part of Texas v United States.
The U.S. House of Representatives voted overwhelmingly last night to approve the Eliminating Opioid-Related Infectious Disease Act and the Substance Use Disorder Loan Repayment Act of 2018.
New data released by the Centers for Disease Control and Prevention document that invasive methicillin-resistant Staphylococcus aureus (MRSA) infections occurring in people who inject drugs more than doubled, from 4.1 percent to 9.2 percent between 2011 and 2016.
The lawsuit filed today by Lambda Legal and OutServe-SLDN against the Department of Defense on behalf of Sgt. Nick Harrison, a military service member living with HIV, is a reminder that misconceptions surrounding HIV infection continue to contribute to stigma and discrimination and compromise the rights of people living with HIV.
The Ebola outbreak in the Democratic Republic of Congo announced May 8 has highlighted meaningful advances as well as critical needs that continue in the wake of the epidemic across Sierra Leone, Guinea and Liberia that ended two years ago.
The Trump Administration’s intention to bar Title X Family Planning Program-funded women’s reproductive healthcare providers from providing counseling on abortion or from offering abortion services, violates key tenants of the Medical Code of Ethics, is an unacceptable government intrusion on the provider and patient relationship, constitutes a threat to the health and lives of low income women, and will undermine efforts to prevent HIV infections and sexually transmitted diseases.
The Infectious Diseases Society of America, the HIV Medicine Association the Pediatric Infectious Diseases Society and the Society for Healthcare Epidemiology of America call on Congress to reject legislative attempts, including House Resolution 3 introduced Wednesday evening, that advance the Trump administration’s rescissions package.
The Eliminating Opioid-Related Infectious Disease Act and the Substance Use Disorder Loan Repayment Act under consideration by the House Energy and Commerce Committee today recognize that responses to the national opioid epidemic must include responses to its accompanying public and individual health threats.
The Infectious Diseases Society of America, the HIV Medicine Association, and the Pediatric Infectious Diseases Society commend House and Senate panels approving legislation this week that demonstrated a commitment to confronting the opioid crisis comprehensively and effectively.
The U.S. government response to the global impacts of HIV and tuberculosis is poised at a pivotal moment, in which we can seize the opportunity to end these devastating pandemics, or watch progress erode, infections increase, and our effective treatments compromised by growing drug resistance.